Unknown

Dataset Information

0

(4R)-4-Benzyl-3-{(4S)-4-chloro-4-[(S)-2,2-dimethyl-1,3-dioxolan-4-yl]butano-yl}-1,3-oxazolidin-2-one.

ABSTRACT: The title compound, C(19)H(24)ClNO(5), was synthesized and subsequently employed in an Evans alkyl-ation. The purpose was to prove the absolute configuration in the projected synthesis of the side chain of (-)-Lytophilippine A. The oxazolidinone and the isopropylidene acetal rings have twisted conformations. The oxazolidinone and side-chain carbonyl groups are orientated in an anti-periplanar arrangement to minimize van der Waals repulsions. Furthermore, the Cl atom and the acetonide-protected secondary alcohol are also in an anti-periplanar arrangement with a torsion angle of 173.64?(14)°. The absolute configuration was determined and agrees with the configuration of the used chiral auxiliary.

SUBMITTER: Bording S 

PROVIDER: S-EPMC3254509 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

(4R)-4-Benzyl-3-{(4S)-4-chloro-4-[(S)-2,2-dimethyl-1,3-dioxolan-4-yl]butano-yl}-1,3-oxazolidin-2-one.

Börding Sandra S   Strohmann Carsten C   Preut Hans H   Hiersemann Martin M  

Acta crystallographica. Section E, Structure reports online 20111217 Pt 1

The title compound, C(19)H(24)ClNO(5), was synthesized and subsequently employed in an Evans alkyl-ation. The purpose was to prove the absolute configuration in the projected synthesis of the side chain of (-)-Lytophilippine A. The oxazolidinone and the isopropylidene acetal rings have twisted conformations. The oxazolidinone and side-chain carbonyl groups are orientated in an anti-periplanar arrangement to minimize van der Waals repulsions. Furthermore, the Cl atom and the acetonide-protected s  ...[more]

Similar Datasets

Unknown (4S)-4-Benzyl-N-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]sulfon-yl}-2-oxo-1,3-oxazolidine-3-carboxamide.
| S-EPMC3007004 | biostudies-literature
Unknown (S)-3-Dimethyl-amino-2-{(4S,5R)-5-[(R)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}-2-hydroxy-propanoic acid.
| S-EPMC2915345 | biostudies-literature
Unknown (4S)-4-[(R)-Chloro-(4-nitro-phen-yl)meth-yl]-1,3-oxazolidin-2-one.
| S-EPMC3648307 | biostudies-literature
Unknown (2S,4S)-3-Benzoyl-4-benzyl-2-tert-but-yl-1,3-oxazolidin-5-one.
| S-EPMC3435759 | biostudies-literature
Unknown (2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-carboxy-propanoate.
| S-EPMC2969742 | biostudies-literature
Unknown (4S)-(-)-4-Benzyl-2,2-dimethyl-3-o-toluoyl-1,3-oxazolidine.
| S-EPMC3009175 | biostudies-literature
Unknown (R)-2-[(R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-1,3-oxathio-lan-5-one.
| S-EPMC2969249 | biostudies-literature
Unknown (4R,5S)-4-Hy-droxy-meth-yl-5-[(methyl-sulfanyl)-meth-yl]-1,3-oxazolidin-2-one.
| S-EPMC3393898 | biostudies-literature
Unknown (4-Benzyl-2-oxo-1,3-oxazolidin-5-yl)methyl methane-sulfonate.
| S-EPMC2979937 | biostudies-literature
Unknown (4S,5S)-2-(4-Chloro-phen-yl)-1,3-dioxolane-4,5-dicarboxamide.
| S-EPMC2977328 | biostudies-literature